KYTHERA Biopharmaceuticals Receives $33.3M in Payments from Bayer

KYTHERA Biopharmaceuticals Receives $33.3M in Payments from Bayer

[at noodls] – KYTHERA Biopharmaceuticals Receives $33.3M in Payments from Bayer June 5, 2012 Payments triggered by receipt of positive results from Bayer’s pivotal European Phase III clinical trials for ATX-101 LOS … more

View todays social media effects on KYTH

View the latest stocks trending across Twitter. Click to view dashboard

Share this post